SELLAS Life Sciences Group, Inc. — Director's Dealing 2015

Jul 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2015-06-25

Reporting Person: Knapp Thomas J (General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-25	Stock Option (right to buy)	$1.83	A	40000	Acquired	2025-06-25	Common Stock (40000)	Direct

Footnotes

F1: Granted pursuant to the Issuer's Amended and Restated 2007 Incentive Plan.

F2: The stock option vests in six approximately equal monthly installments as of the end of each month commencing July 31, 2015 and ending December 31, 2015, subject to the Reporting Person remaining in the Issuer's continuous employ through each monthly vesting date.